Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhongtongning Cataplasm (肿痛宁巴布贴) is a Chinese topical transdermal patch (cataplasm) used for the relief of swelling and pain, particularly in musculoskeletal conditions such as joint pain, soft tissue injuries, and localized inflammation. It is based on traditional Chinese medicine principles and typically contains herbal extracts with purported effects of dispelling wind and dampness, reducing swelling, and alleviating pain. The mechanism of action involves local anti-inflammatory and analgesic effects through skin absorption. The product is designed for external use only; it is applied directly to the affected area to deliver active ingredients transdermally over an extended period[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhongtongning cataplasm.